A A Lammertsma Selected Research

A A Lammertsma Research Topics

Disease

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2020 - 03/2002
3	Rheumatoid Arthritis 01/2019 - 11/2007
3	Neoplasms (Cancer) 01/2017 - 06/2000
3	Alzheimer Disease (Alzheimer's Disease) 04/2015 - 12/2009
2	Colorectal Neoplasms (Colorectal Cancer) 12/2016 - 10/2014
2	Cognitive Dysfunction 12/2014 - 12/2009
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 12/2013 - 04/2010
2	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 02/2001 - 04/2000
1	Arthritis (Polyarthritis) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2015
1	Atrophy 12/2014
1	Brain Diseases (Brain Disorder) 12/2014
1	Dementia (Dementias) 12/2014
1	Pathologic Processes 12/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2014
1	Aortic Valve Stenosis (Aortic Stenosis) 12/2013
1	Heart Diseases (Heart Disease) 12/2013
1	Inflammation (Inflammations) 04/2009
1	Breast Neoplasms (Breast Cancer) 08/2008
1	Parkinson Disease (Parkinson's Disease) 08/2008
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2008
1	Osteoarthritis 11/2007
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2006
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2001
1	Ischemia 05/2001
1	Tachycardia (Tachyarrhythmias) 02/2001
1	Ventricular Tachycardia 04/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2013
2	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2019 - 04/2009
2	Cetuximab (Erbitux)FDA Link 12/2016 - 10/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2015 - 08/2008
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2014 - 12/2009
2	Acetates (Acetic Acid Esters)FDA Link 12/2013 - 04/2010
2	GABA-A Receptors (GABA(A) Receptor)IBA 04/2009 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 11/2007 - 05/2001
2	CatecholaminesIBA 02/2001 - 04/2000
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2001 - 06/2000
1	AfatinibIBA 08/2020
1	ErbB Receptors (EGF Receptor)IBA 08/2020
1	Tyrosine Kinase InhibitorsIBA 08/2020
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2019
1	CalciumIBA 09/2015
1	Amyloid (Amyloid Fibrils)IBA 12/2014
1	Indicators and Reagents (Reagents)IBA 12/2014
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	2- (1- (6- ((2- fluoroethyl)(methyl)amino)- 2- naphthyl)ethylidene)malononitrileIBA 12/2009
1	PK 11195 (PK11195)IBA 04/2009
1	Fluorouracil (Carac)FDA LinkGeneric 08/2008
1	EnzymesIBA 08/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2008
1	alovudineIBA 08/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2008
1	Pharmaceutical PreparationsIBA 01/2008
1	LigandsIBA 01/2008
1	Flumazenil (Romazicon)FDA LinkGeneric 01/2008
1	BenzodiazepinesIBA 01/2008
1	Dipyridamole (Persantine)FDA LinkGeneric 05/2001
1	Vasodilator Agents (Vasodilators)IBA 05/2001
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2001
1	Adrenergic Agents (Adrenergic Drugs)IBA 04/2000
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2000
1	beta Adrenergic ReceptorsIBA 04/2000
1	Anti-Arrhythmia AgentsIBA 04/2000

Therapy/Procedure

2	Therapeutics 01/2017 - 06/2000
2	Drug Therapy (Chemotherapy) 02/2014 - 08/2008
1	Precision Medicine 01/2017
1	Chemoradiotherapy 02/2014
1	Carotid Endarterectomy 01/2006
1	Induction Chemotherapy 03/2002